Tag: AstraZeneca

Veteran pharmaceutical company AstraZeneca (NASDAQ: AZN) saw its shares rise over 3% on a typically down day for the market, ...

President Donald Trump announced a deal with AstraZeneca to provide lower-cost prescription drugs to American consumers, promising significant discounts on ...

AstraZeneca has licensed Algen Biotechnologies' AI-driven gene-editing platform, AlgenBrain, for up to $555 million to develop therapies for immune-related disorders, ...

Shares of AstraZeneca (NASDAQ: AZN) surged over 10% this week following positive clinical results for Enhertu in HER2-positive breast cancer ...

British pharmaceutical giant AstraZeneca announced a $2.5 billion investment in a research and development center in Beijing, boosting its workforce ...

Rachel Reeves' hopes to regain business confidence suffered a blow as AstraZeneca cancelled a £450 million investment in a vaccine ...

AstraZeneca has issued a warning to move vaccine manufacturing from the UK to the US due to supply chain issues, ...